Research Topics
Species | Vincenzo CannizzaroSummaryAffiliation: University of Zurich Country: Switzerland Publications
|
Detail Information
Publications
Thrombolysis of venous and arterial thrombosis by catheter-directed low-dose infusion of tissue plasminogen activator in childrenVincenzo Cannizzaro
Division of Intensive Care, University Children s Hospital, Zurich, Switzerland
J Pediatr Hematol Oncol 27:688-91. 2005..Catheter-directed low-dose thrombolysis is an efficient treatment option for severe venous and arterial thrombosis in children...
Congenital prothrombotic disorders in children with peripheral venous and arterial thrombosesManuela Albisetti
Division of Hematology, University Children s Hospital, Zurich, Switzerland
Acta Haematol 117:149-55. 2007..To evaluate the prevalence of congenital prothrombotic disorders in children with peripheral venous and arterial thromboses...
Antithrombin activity in children with chylothoraxVera Bernet-Buettiker
Division of Neonatology and Intensive Care, University Children s Hospital, Steinwiesstrasse 75, CH 8032 Zurich, Switzerland
Eur J Cardiothorac Surg 29:406-9. 2006..To determine whether increased antithrombin loss is present in children with chylothorax after cardiac surgery...
Determinants of arterial and central venous blood pressure variation in ventilated critically ill childrenEva Kühlwein
Department of Paediatric Intensive Care and Neonatology, University Children s Hospital, Steinwiesstr 75, 8032 Zurich, Switzerland
Intensive Care Med 37:118-23. 2011..Several factors are known to influence the interpretability of these variations. We analysed ventilation-induced variations in critically ill children with reference to ventilatory and circulatory parameters...
The role of somatostatin in the treatment of persistent chylothorax in childrenVincenzo Cannizzaro
Department of Neonatology and Intensive Care, University Children's Hospital, Steinwiesstrasse 75, CH 8032 Zurich, Switzerland
Eur J Cardiothorac Surg 30:49-53. 2006..With this strategy, some children may be prevented from undergoing an operation. However, factors predicting successful therapy with somatostatin could not be elicited...
